Decompensated Cirrhosis
Conditions
Interventions
Trial Group:Ascites self-management intervention program + routine care, face-to-face intervention during hospitalization, online intervention (WeChat/phone) after discharge
each session 30-45 minutes, once daily in weeks 1-2, twice weekly in weeks 3-4, intervention duration of 4 weeks, follow-up visit at week 8 after intervention.
Control Group:Routine care including admission education, assistance with management, nursing procedures according to medical orders, dietary guidance, rest and activity guidance, condition monitoring
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Diagnosis of decompensated liver cirrhosis with ascites complications according to the Chinese Clinical Diagnosis and Treatment Consensus for Liver Cirrhosis(2023); 2.Classified as Grade B or C according to the Child-Pugh liver function grading system. 3.Ascites grade 2 or 3 according to the ascites grading system. 4.Aged 18 to 75 years old. 5.Conscious, informed of the diagnosis, capable of independent communication, and has signed the informed consent form. 6.Possess a smartphone with internet access and have the WeChat application installed; able to independently or with assistance from the primary caregiver perform basic WeChat operations (including viewing health information, online communication, submitting assignments, and video-based learning). 7.Receives a stable, standardized, and relatively uniform basic treatment regimen for liver cirrhosis during the study period.
Exclusion criteria
Exclusion criteria: 1.Critically ill patients requiring ??emergency resuscitation??; 2.Severe ??cognitive impairment?? or ??psychiatric disorders?? affecting compliance; 3.Unwilling or unable to cooperate with study protocols; 4.Diagnosed with ??refractory (intractable) ascites?? per ascites typing criteria; 5.Concurrent severe systemic diseases (e.g., ??advanced heart failure, terminal cancer, end-stage renal disease??); 6.Participation in other ??interventional clinical trials?? within the past ??4 weeks??.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ascites depth; | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of ascites resolution;Total score of self-management behaviors;Incidence and severity of symptoms;Self-efficacy level;Adherence rate to self-management intervention program; | — |
Countries
China
Contacts
Public ContactYang Sha
The First Affiliated Hospital of Army Medical University
Outcome results
None listed